JLE

European Journal of Dermatology

MENU

Re: Article: “Skin problems associated with pegylated liposomal doxorubicin – more than palmoplantar erythrodysesthesia syndrome” by Mangana et al., Eur J Dermatol 2008; 18 (5): 566-70 Volume 19, issue 3, May-June 2009

Authors
Medical Oncology, Kantonsspital Graubünden, Loestrasse 170, CH-7000 Chur, Switzerland

Auteur(s) : Roger Von Moos, Richard Cathomas Medical Oncology, Kantonsspital Graubünden, Loestrasse 170, CH-7000 Chur, Switzerland With interest we have read the article by Mangana et al. [1] on skin toxicities associated with pegylated liposomal doxorubicin (PLD, Caelyx®/Doxil®). They report six cases of severe palmar-plantar erythrodysesthesia (PPE, hand-foot syndrome). Three of these patients experienced classical PPE, while one patient had PPE with extensive bullous disease; one patient developed [...]